These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12908007)

  • 21. [Pharmacology of uxepam].
    Zakusov VV; Voronina TA; Garibova TL; Pálosi E; Sporni L
    Farmakol Toksikol; 1983; 46(6):5-9. PubMed ID: 6140185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of anxiolytic drugs on some behavioral consequences in olfactory bulbectomized rats.
    Wierońska JM; Papp M; Pilc A
    Pol J Pharmacol; 2001; 53(5):517-25. PubMed ID: 11990071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of the aversive effects of drugs in self-administration: assessing the balance of reward and aversion in drug-taking behavior.
    Verendeev A; Riley AL
    Behav Pharmacol; 2013 Sep; 24(5-6):363-74. PubMed ID: 23863641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Anxiolytic drugs and inhibition].
    Zarifian E
    Encephale; 1978; 4(5 Suppl):547-51. PubMed ID: 38106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anxiolytic-like action of neuropeptide Y: mediation by Y1 receptors in amygdala, and dissociation from food intake effects.
    Heilig M; McLeod S; Brot M; Heinrichs SC; Menzaghi F; Koob GF; Britton KT
    Neuropsychopharmacology; 1993 Jun; 8(4):357-63. PubMed ID: 8099792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Consistent rewarding or aversive effects of the electrical stimulation of the lateral parabrachial complex.
    Simon MJ; Zafra MA; Molina F; Puerto A
    Behav Brain Res; 2008 Jun; 190(1):67-73. PubMed ID: 18400314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anxiolytic effects of yokukansan, a traditional Japanese medicine, via serotonin 5-HT1A receptors on anxiety-related behaviors in rats experienced aversive stress.
    Yamaguchi T; Tsujimatsu A; Kumamoto H; Izumi T; Ohmura Y; Yoshida T; Yoshioka M
    J Ethnopharmacol; 2012 Sep; 143(2):533-9. PubMed ID: 22819689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reinforcement schedules and extrapolations to humans from animals in behavioral pharmacology.
    Cook L; Sepinwall J
    Fed Proc; 1975 Aug; 34(9):1889-97. PubMed ID: 238869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of cholinergic drugs on aversive operant behavior induced by dorsal central gray stimulation in rats.
    Moriyama M; Ichimaru Y; Gomita Y; Fukuda T
    Jpn J Pharmacol; 1985 Nov; 39(3):339-47. PubMed ID: 4094182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic effects of ethanol and cocaine on brain stimulation reward.
    Lewis MJ; June HL
    J Exp Anal Behav; 1994 Mar; 61(2):223-9. PubMed ID: 8169571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Free versus forced exposure to an elevated plus-maze: evidence for new behavioral interpretations during test and retest.
    Roy V; Chapillon P; Jeljeli M; Caston J; Belzung C
    Psychopharmacology (Berl); 2009 Mar; 203(1):131-41. PubMed ID: 18998112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anxiolytic properties of green tea polyphenol (-)-epigallocatechin gallate (EGCG).
    Vignes M; Maurice T; Lanté F; Nedjar M; Thethi K; Guiramand J; Récasens M
    Brain Res; 2006 Sep; 1110(1):102-15. PubMed ID: 16859659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intracranial self-stimulation and immobilization had different effects on neurite extension and the p38 MAPK pathway in PC12m3 cells.
    Gomita Y; Esumi S; Kitamura Y; Motoda H; Sendo T; Sagara H; Araki H; Mio M; Inoue S; Kano Y
    Life Sci; 2017 Dec; 190():78-83. PubMed ID: 28964814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anxiolytic drugs selectively increase preferred duration of rewarding brain stimulation in a shuttlebox test.
    Gerhardt S; Prowse J; Liebman JM
    Pharmacol Biochem Behav; 1982 May; 16(5):795-9. PubMed ID: 6124010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anxiolytic-like actions of buspirone in a runway model of intravenous cocaine self-administration.
    Ettenberg A; Bernardi RE
    Pharmacol Biochem Behav; 2006 Oct; 85(2):393-9. PubMed ID: 17064759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neural substrates of behavioral aversion in lateral hypothalamus of rabbits.
    Schwartzbaum JS; Leventhal TO
    Brain Res; 1990 Jan; 507(1):85-91. PubMed ID: 2302583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cocaine and SKF-82958 potentiate brain stimulation reward in Swiss-Webster mice.
    Gilliss B; Malanga CJ; Pieper JO; Carlezon WA
    Psychopharmacology (Berl); 2002 Sep; 163(2):238-48. PubMed ID: 12202971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repeated cocaine decreases the avoidance response to a novel aversive stimulus in rats.
    Sorg BA; Davidson DL; Hochstatter T; Sylvester PW
    Psychopharmacology (Berl); 2002 Aug; 163(1):9-19. PubMed ID: 12185395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of antianxiety and antipsychotic drugs on DRL responding for brain stimulation.
    Ichimaru Y; Moriyama M; Gomita Y
    Life Sci; 1983 Jan; 32(5):437-48. PubMed ID: 6130461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of GABAergic drugs on brain stimulation reward as assessed by a 'threshold' method.
    Zarevics P; Setler PE
    Brain Res; 1981 Jun; 215(1-2):201-9. PubMed ID: 7260588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.